Answers are grounded in this paper and cite their sources.
Objective: Study of severe visceral damage in systemic scleroderma in the rheumatology Department of CHU de Cocody. Patients and Methods: We conducted a retrospective descriptive study of the records of patients hospitalised for systemic scleroderma according to ACR/EULAR 2013 criteria in the rheumatology Department of CHU de Cocody over an 11-year period from January 1, 2005 to December 31, 2016. Results: A total of 18 patients had systemic scleroderma, 10 of whom had severe visceral damage with a frequency of 55.5%. All patients were female. The mean age was 34.5 ± 15.4 years. The mean duration of the disease was 3.5 ± 4.1 years. Clinically, 7 patients (70%) had a dry cough, 5 (50%) had stage dyspnoea and 2 (20%) had palpitations. Serious damage was pulmonary, cardiac and digestive in 8 patients (80%), 4 patients (40%) and 3 patients (30%) respectively. Pulmonary damage was mainly a combination of pulmonary arterial hypertension and interstitial lung disease in 5 patients (62.5%). Cardiac damage was represented by pericarditis in 3 patients (75%). Gastro-oesophageal reflux disease occurred in 2 patients (66.7%). Biologically, anti-nuclear antibodies were positive in all patients, Anti-Scl-70 in 44.4% and anti-centromeres in 22.2%. The course was marked by 3 deaths due to cardiovascular failure. Conclusion: Severe visceral damage is common in systemic scleroderma, dominated by cardiac and pulmonary attacks.
No takes yet. Share an insight, caveat, or question.
Sompougdou et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: